Michael O Mireku1,2,3, Leslie L Davidson4, Michael J Boivin5, Romeo Zoumenou6, Achille Massougbodji6, Michel Cot7,8, Florence Bodeau-Livinec3,9. 1. Institut de Recherche pour le Développement (IRD), Mère et Enfant Face aux Infections Tropicales, Paris, France; michael.osei.mireku@gmail.com. 2. Université Pierre et Marie Curie, Ecole Doctorale Pierre Louis de Santé Publique, Paris, France. 3. Département Méthodes Quantitatives en Santé Publique, Ecole des Hautes Etudes en Santé Publique, Rennes, France. 4. Mailman School of Public Health and the College of Physicians and Surgeons, Columbia University, New York, New York. 5. Departments of Psychiatry and Neurology/Ophthalmology, Michigan State University, East Lansing, Michigan. 6. Faculté des Sciences de la Santé, Université d'Abomey-Calavi, Cotonou, Bénin. 7. Institut de Recherche pour le Développement (IRD), Mère et Enfant Face aux Infections Tropicales, Paris, France. 8. PRES Sorbonne Paris Cité, Faculté des Sciences Pharmaceutiques et Biologiques, Université Paris Descartes, Paris, France; and. 9. Inserm UMR 1153, Obstetrical, Perinatal and Pediatric Epidemiology Research Team (Epopé), Center for Epidemiology and Statistics Sorbonne Paris Cité, DHU Risks in Pregnancy, Paris Descartes University, Paris, France.
Abstract
OBJECTIVE: To investigate the impact of prenatal maternal iron deficiency (ID) on cord blood serum ferritin (CBSF) concentration and infant cognitive and motor development. METHODS: Our prospective cohort study included 636 mother-singleton child pairs from 828 eligible pregnant women who were enrolled during their first antenatal care (ANC) visit in Allada, Benin, into a clinical trial comparing the efficacy of mefloquine and sulfadoxine-pyrimethamine. Venous blood samples of women were assessed for ferritin and hemoglobin concentrations at the first and second ANC visits (occurring at least 1-month apart) and at delivery. Women were prescribed daily iron and folic acid supplements throughout pregnancy. Hematologic examinations were repeated for cord blood at birth. At age 1 year, cognitive and motor functions of children were assessed by using the Mullen Scales of Early Learning. RESULTS: The prevalence of prenatal ID at first and second ANC visits, and at delivery was 30.5%, 34.0%, and 28.4%, respectively. CBSF concentrations were similar between ID and non-ID pregnant women. Neither prenatal ID nor CBSF concentration was associated with poor cognitive or gross motor function of children at age 1 year. CBSF concentrations were lower among mothers who had ID anemia (IDA) at delivery compared with non-IDA pregnant women (adjusted mean difference: -0.2 [95% confidence interval: -0.4 to -0.0]). CONCLUSIONS: In a malaria-endemic region, ID in pregnancy in the context of iron supplementation is neither associated with CBSF concentration nor with infant cognitive and motor development. Prenatal IDA around the time of delivery is associated with lower CBSF concentrations.
OBJECTIVE: To investigate the impact of prenatal maternal iron deficiency (ID) on cord blood serum ferritin (CBSF) concentration and infant cognitive and motor development. METHODS: Our prospective cohort study included 636 mother-singleton child pairs from 828 eligible pregnant women who were enrolled during their first antenatal care (ANC) visit in Allada, Benin, into a clinical trial comparing the efficacy of mefloquine and sulfadoxine-pyrimethamine. Venous blood samples of women were assessed for ferritin and hemoglobin concentrations at the first and second ANC visits (occurring at least 1-month apart) and at delivery. Women were prescribed daily iron and folic acid supplements throughout pregnancy. Hematologic examinations were repeated for cord blood at birth. At age 1 year, cognitive and motor functions of children were assessed by using the Mullen Scales of Early Learning. RESULTS: The prevalence of prenatal ID at first and second ANC visits, and at delivery was 30.5%, 34.0%, and 28.4%, respectively. CBSF concentrations were similar between ID and non-ID pregnant women. Neither prenatal ID nor CBSF concentration was associated with poor cognitive or gross motor function of children at age 1 year. CBSF concentrations were lower among mothers who had ID anemia (IDA) at delivery compared with non-IDA pregnant women (adjusted mean difference: -0.2 [95% confidence interval: -0.4 to -0.0]). CONCLUSIONS: In a malaria-endemic region, ID in pregnancy in the context of iron supplementation is neither associated with CBSF concentration nor with infant cognitive and motor development. Prenatal IDA around the time of delivery is associated with lower CBSF concentrations.
Authors: Jie Shao; Jingan Lou; Raghavendra Rao; Michael K Georgieff; Niko Kaciroti; Barbara T Felt; Zheng-Yan Zhao; Betsy Lozoff Journal: J Nutr Date: 2012-09-26 Impact factor: 4.798
Authors: Rosa M Angulo-Barroso; Ming Li; Denise C C Santos; Yang Bian; Julie Sturza; Yaping Jiang; Niko Kaciroti; Blair Richards; Betsy Lozoff Journal: Pediatrics Date: 2016-03-02 Impact factor: 7.124
Authors: Béatrice Koba Bora; Ana Luiza Ramos-Crawford; Alla Sikorskii; Michael Joseph Boivin; Didier Malamba Lez; Dieudonné Mumba-Ngoyi; Abdon Mukalay Wa Mukalay; Daniel Okitundu-Luwa; Desiré Tshala-Katumbay Journal: Brain Res Bull Date: 2018-06-23 Impact factor: 4.077
Authors: Margaret Nampijja; Agnes M Mutua; Alison M Elliott; John Muthii Muriuki; Amina Abubakar; Emily L Webb; Sarah H Atkinson Journal: Nutrients Date: 2022-03-30 Impact factor: 5.717
Authors: Hugo G Quezada-Pinedo; Florian Cassel; Liesbeth Duijts; Martina U Muckenthaler; Max Gassmann; Vincent W V Jaddoe; Irwin K M Reiss; Marijn J Vermeulen Journal: Nutrients Date: 2021-06-28 Impact factor: 5.717